Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Correlation of cancer risk evaluation and early detection (CADET) scores with abnormal ultrasonographic ovarian findings
1Departments of Obstetrics and Gynecology, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
2Internal Medicine “H”, Tel-Aviv Sourasky Medical Center Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv , Israel
*Corresponding Author(s): D. Grisaru E-mail: grisaro@post.tau.ac.il
Objective: To determine the utility of a modified version of ovarian cancer-focused cancer risk evaluation and early detection (CADET) scores as a screening tool for ultrasonographic ovarian findings. Study design: Prospective pilot study. Main outcome measures: CADET scores were compared with abnormal ultrasonographic ovarian findings of peri- and postmenopausal women who attended their gynecologist for a routine check-up. The women filled in the CADET questionnaire before seeing their gynecologists who were blinded to the CADET results. The women whom they referred for pelvic transvaginal ultrasonographic examination comprised the study group. The results of their scans were compared with their CADET scores. Results: Of the 181 peri- and postmenopausal women who were candidates for this study, 154 were referred for ultrasonography, of whom 38 (24%, Group A) had abnormal ovarian scans (30 simple cysts and 8 complex findings). The other 116 (76%) women had normal sonograms (Group B). Demographic characteristics were similar for both groups. Thirteen Group A women (34%) and 52 Group B women (45%) had positive CADET scores (p = NS). The average group CADET scores were also not significantly different (0.8 +/- 1.7 for Group A and 1.7 +/- 2.5 for Group B). Conclusion: CADET scores did not correlate with abnormal ultrasonographic ovarian findings.
J. Hasson,G. Rattan,I. Heller,J.B. Lessing,D. Grisaru. Correlation of cancer risk evaluation and early detection (CADET) scores with abnormal ultrasonographic ovarian findings. European Journal of Gynaecological Oncology. 2012. 33(3);265-268.
[1] Jemal A., Clegg L.X., Ward E., Ries L.A., Wu X., Jamison P.M.: “Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival”. Cancer 2004, 101, 3.
[2] Daly M.B., Ozols R.F.: “Symptoms of ovarian cancer – where to set the bar?”. JAMA, 2004, 291, 2755.
[3] Karlan K.B.: “Screening for ovarian cancer: what are the optimal surrogate endpoints for clinical trials?”. J. Cell. Biochem. Suppl., 1995, 23, 227.
[4] De Priest P.D., DeSimone C.P.: “Ultrasound screening for the early detection of ovarian cancer”. J. Clin. Oncol., 2003, 21, 194.
[5] Bast R.C.: “Status of tumor markers in ovarian cancer screening”. J. Clin. Oncol., 2003, 21, 200s.
[6] National Institutes of Health Consensus Development Conference Statement. Ovarian cancer: screening, treatment, and follow-up. Gynecol. Oncol., 1994, 55, S4-14. Review.
[7] Olson S.H., Mignone L., Nakraseive C., Caputo T.A., Barakat R.R., Harlap S.: “Symptoms of ovarian cancer”. Obstet. Gynecol., 2001, 98, 212.
[8] Eastman P.: “Task force issues new screening guidelines”. J. Natl. Cancer Inst., 1996, 88, 74.
[9] ACOG Committee on Gynecologic Practice. The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. Int. J. Gynaecol. Obstet., 2003, 80, 235.
[10] Vine M.F., Calingaert B., Berchuck A., Schildkraut J.M.: “Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls”. Gynecol. Oncol., 2003, 90, 75.
[11] Bell R., Petticrew M., Sheldon T.: “The performance of screening tests for ovarian cancer: results of a systematic review”. Br. J. Obstet. Gynaecol., 1998, 105, 1136.
[12] Friedman G.D., Skilling J.S., Udaltsova N.V., Smith L.H.: “Early symptoms of ovarian cancer: a case-control study without recall bias”. Fam. Pract., 2005, 22, 548.
[13] Smith L.H., Morris C.R., Yasmeen S., Parikh-Patel A., Cress R.D., Romano P.S.: “Ovarian cancer: can we make the clinical diagnosis earlier?”. Cancer, 2005, 104, 1398.
[14] Goff B.A., Mandel L.S., Drescher C.W., Urban N., Gough S., Schurman K.M. et al.: “Development of an ovarian cancer symptom index: possibilities for earlier detection”. Cancer, 2007, 109, 221.
[15] Goff B.A., Matthews B.J., Wynn M., Muntz H.G., Lishner D.M., Baldwin L.M.: “Ovarian cancer: patterns of surgical care across the United States”. Gynecol. Oncol., 2006, 103, 383.
[16] Webb P.M., Purdie D.M., Grover S., Jordan S., Dick M.L., Green A.C.: “Symptoms and diagnosis of borderline, early and advanced epithelial ovarian cancer”. Gynecol. Oncol., 2004, 92, 232.
[17] Heller I., Isakov A., Villa Y., Natour H., Inbar M., Fuchs J. et al.: “Evaluation of CaDet, a computer-based clinical decision support system for early cancer detection: a comparison with the performance of clinicians”. Cancer Detect. Prev., 2004, 28, 352.
[18] Fuchs J., Heller I., Topilsky M., Inbar M.: “CaDet, a computerbased clinical decision support system for early cancer detection”. Cancer Detect. Prev., 1999, 23, 78.
[19] Kim M.K., Kim K., Kim S.M., Kim J.W., Park N.H., Song Y.S. et al.: “A hospital based case control study of identifying ovarian cancer using symptom index”. J. Gynecol. Oncol., 2009, 20, 238.
[20] Pavlic E.J., Saunders B.A., Doran S., McHugh K.W., Ueland F.R., Desimone C.P. et al.: “The search for meaning - Symptoms and transvaginal sonography screening for ovarian cancer”. Cancer, 2009, 115, 3689.
Top